# Alex Iskold

> Alex Iskold is a pre-seed investor at The $1K Project Ukraine backing Software and Health Care. See 112 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [The $1K Project Ukraine](https://shizune.co/investors/profile/the-1k-project-ukraine)
- Location: New York, United States
- Total investments: 112
- Last investment: May 2026
- Lead investor: 26%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/in/iskold
- X (Twitter): http://twitter.com/alexiskold
- Website: http://alexiskold.net/

Alex Iskold Is a Founder and a Managing Partner at 2048 Ventures. Prior to founding 2048 ventures, Alex spent 5 years at Techstars as the Managing Director of its NYC program. Alex was also the founder and CEO of Info Lab (acquired by IBM), founder and CEO of GetGlue (backed by USV, RRE, and Time Warner), and a Chief Architect of distributedcomputing startup DataSynapse (acquired by TIBCO). Alex currently serves as a Coach and a VC in Residence at the Harvard Business School. Alex previously taught an award-winning undergraduate computer science class at NYU. He holds a B.S. in Math with Honors from Lehigh University and M.S. in Computer Science from NYU.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 21 | 19% |
| Health Care | 13 | 12% |
| Artificial Intelligence | 12 | 11% |
| Information Technology | 10 | 9% |
| Analytics | 9 | 8% |

163 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Pre-Seed | 45 | 40% |
| Seed | 40 | 36% |
| Series A | 7 | 6% |
| Series B | 4 | 4% |
| Convertible Note | 3 | 3% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 70 | 63% |
| Canada | 6 | 5% |
| Israel | 1 | 1% |
| South Korea | 1 | 1% |
| United Kingdom | 1 | 1% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Century Health | Century Health accelerates drug development and commercialization by applying AI to real-world data. It is far too slow today to answer critical questions because the richest clinical data is locked away in silos. Our platform does the heavy lifting to rapidly get you the insight you need, all while supporting the research community and protectingpatient privacy. | $5M | Seed | May 19, 2026 |  |
| Laminar | IoT-enabled analytics platform providing data-driven optimization of industrial liquid systems for manufacturing | $12M | Series A | Jul 16, 2025 |  |
| Nimbus Health | Our mission is to redefine the standard of care in pulmonary medicine and deliver the best lung care in America. We’re rebuilding the pulmonary clinic around a technology platform and a set of virtual and physical interventions calibrated to keep lung conditions under control. At a Nimbus Clinic, rich patient data and predictive models allow ourproviders to make more thoughtful medical decisions, and step in at exactly the right moment. | $12M | Seed | May 13, 2025 |  |
| Variant AI | Variant AI is a technology company specializing in applying generative AI to game development. |  | Pre-Seed | Feb 17, 2025 |  |
| Humane Genomics | Humane Genomics is a virus development platform that develops artificial viruses to cure diseases. The company was founded in 2019 and is headquartered in New York, United States. | $4M | Seed | Feb 12, 2025 |  |
| Laminar | IoT-enabled analytics platform providing data-driven optimization of industrial liquid systems for manufacturing |  | Series A | Jan 16, 2025 |  |
| Impilo | Impilo is a developer of digital health operating systems aimed at improving the infrastructure underlying remote healthcare. Through its full-stack middleware technology, the company's systems provide an e-commerce and application programming interface for handling purchases, logistics, and configuration, allowing hospitals and healthcareorganizations to manage their digital health remote patient monitoring devices and supplies. | $11.5M | Series A | Nov 14, 2024 |  |
| Nomic | Nomic is a bioengineering company working to make the human proteome as broadly and easily accessible as the human genome. They are building the nELISA, a next-generation protein profiling platform for measuring proteins at scale and at high throughput. They offer scientists protein profiling solutions and empower them to decide the scope and scaleof their experiments. | $42M | Series B | Sep 17, 2024 |  |
| Growth Signals | Growth Signals is an AI-powered system of record and communication for corporate innovation. |  | Seed | Aug 18, 2024 |  |
| Tetsuwan Scientific | Pioneering the development of AI agents capable of wet lab experimentation. | $2.7M | Pre-Seed | Apr 18, 2024 |  |

10 of 112 investments shown.

## Co-investors
- [Techstars](https://shizune.co/investors/profile/techstars) — VC Fund, 61 deals together
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund, 28 deals together
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund, 9 deals together
- [Techstars](https://shizune.co/investors/profile/techstars-new-york-city-accelerator) — VC Fund, 8 deals together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 6 deals together
- [Flybridge](https://shizune.co/investors/profile/flybridge-capital) — VC Fund, 5 deals together

## About The $1K Project Ukraine

VC Fund

The $1K Project Ukraine is a volunteer-based effort to connect sponsors in the USA and around the world to help Ukrainian families impacted by the war.

1 contacts available at The $1K Project Ukraine.

| Name | Title | Profile |
| --- | --- | --- |
| Alex Iskold | Founder | https://shizune.co/investors/profile/alex-iskold |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

## FAQ

### What does Alex Iskold invest in?

Alex Iskold invests primarily in Software, Health Care and Artificial Intelligence startups, most often at Pre-Seed and Seed stage. Most of the 112 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Alex Iskold last invest?

The most recent investment recorded for Alex Iskold closed in May 2026. Shizune tracks 112 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co